Abstract

Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes

Author(s): Trissel Lawrence A, Xu Quanyun A, Pham Lien

Issue: Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine

Page(s): 74-76

Download in electronic PDF format for $75
  • Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Page 1
  • Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Page 2
  • Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Page 3

Abstract

The objective of this study was to evaluate the physical and chemical stability of hydromorphone hydrochloride in concentrations of 1.5 and 80 mg/mL in 0.9% sodium chloride injection packaged in plastic syringes.

Test samples of hydromorphone hydrochloride 1.5- and 80- mg/mL solutions were packaged as 20 mL of drug solution in 30-mL plastic syringes, sealed with plastic tip caps, and stored at 4°C and 23°C for 60 days and at -20°C and 37°C (temperature extremes that might be encountered during shipping) for 2 days. Evaluations for physical and chemical stability were performed initially and throughout the storage periods. Physical stability was assessed by means of visual observation in normal room light with a high-intensity monodirectional light beam. In addition, turbidity and particle content were measured electronically. The chemical stability of the drug was evaluated by means of a stability-indicating high-performance liquid chromatographic (HPLC) analytical technique.

All samples of hydromorphone hydrochloride remained free of visible precipitation throughout the study. Those solutions stored at 4°C, 23°C, or 37°C exhibited little or no change in measured particulate burden and haze level. Freezing the solution resulted in an increase in microparticulate content that did not redissolve when the solution was warmed to room temperature. Little or no loss of hydromorphone hydrochloride occurred in any of the samples at any storage temperature throughout the study. Hydromorphone hydrochloride concentrations were found to be 95% or greater over 60 days at both 4°C and 23°C; concentrations were greater than 97% at both -20°C and 37°C after 2 days.

Hydromorphone hydrochloride solutions at concentrations ranging from 1.5 to 80 mg/mL in 0.9% sodium chloride injection can be packaged in plastic syringes, stored, and shipped with little or no loss of drug. Freezing should be avoided.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2002
Pg. 74-76
Jan/Feb 2002
Pg. 66-69
Jan/Feb 2002
Pg. 70-73
Mar/Apr 2010
Pg. 160-164
May/Jun 2004
Pg. 228-230
May/Jun 2009
Pg. 241
Author(s): Allen Loyd V Jr
Jul/Aug 2008
Pg. 368-371
Jan/Feb 2002
Pg. 62-65
Jul/Aug 2017
Pg. 322-329
May/Jun 2018
Pg. 240-246
May/Jun 2005
Pg. 238-241
Jan/Feb 2021
Pg. 82-87
Nov/Dec 2018
Pg. 504-511
May/Jun 2022
Pg. 248-254
Mar/Apr 2019
Pg. 163-166
Jan/Feb 1998
Pg. 79-82
Jul/Aug 2005
Pg. 320-322
Jul/Aug 2006
Pg. 318-319
Author(s): Gupta Vishnu D
Sep/Oct 2003
Pg. 389-393
Mar/Apr 2008
Pg. 161-162
Author(s): Gupta Vishnu D